Global Hospital Injectable Drugs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Generic Sterile Injectables
1.2.3 Sterile Intravenous (IV) Solutions
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Anesthesia
1.3.4 Anti-Infectives
1.3.5 Parenteral Nutrition
1.3.6 Cardiovascular Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital Injectable Drugs Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Hospital Injectable Drugs Revenue Market Share by Region (2020-2025)
2.4 Global Hospital Injectable Drugs Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Hospital Injectable Drugs Market Size and Prospective (2020-2031)
2.5.2 Europe Hospital Injectable Drugs Market Size and Prospective (2020-2031)
2.5.3 Asia-Pacific Hospital Injectable Drugs Market Size and Prospective (2020-2031)
2.5.4 India Hospital Injectable Drugs Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Hospital Injectable Drugs Historic Market Size by Type (2020-2025)
3.2 Global Hospital Injectable Drugs Forecasted Market Size by Type (2026-2031)
3.3 Different Types Hospital Injectable Drugs Representative Players
4 Breakdown Data by Application
4.1 Global Hospital Injectable Drugs Historic Market Size by Application (2020-2025)
4.2 Global Hospital Injectable Drugs Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Hospital Injectable Drugs Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Hospital Injectable Drugs Players by Revenue (2020-2025)
5.1.2 Global Hospital Injectable Drugs Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Hospital Injectable Drugs Revenue
5.4 Global Hospital Injectable Drugs Market Concentration Analysis
5.4.1 Global Hospital Injectable Drugs Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Hospital Injectable Drugs Revenue in 2024
5.5 Global Key Players of Hospital Injectable Drugs Head office and Area Served
5.6 Global Key Players of Hospital Injectable Drugs, Product and Application
5.7 Global Key Players of Hospital Injectable Drugs, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Hospital Injectable Drugs Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Hospital Injectable Drugs Market Size by Type (2020-2025)
6.1.2.2 North America Hospital Injectable Drugs Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Hospital Injectable Drugs Market Size by Application (2020-2025)
6.1.3.2 North America Hospital Injectable Drugs Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Hospital Injectable Drugs Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Hospital Injectable Drugs Market Size by Type (2020-2025)
6.2.2.2 Europe Hospital Injectable Drugs Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Hospital Injectable Drugs Market Size by Application (2020-2025)
6.2.3.2 Europe Hospital Injectable Drugs Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments and Downstream
6.3.1 Asia-Pacific Hospital Injectable Drugs Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Hospital Injectable Drugs Market Size by Type (2020-2025)
6.3.2.2 Asia-Pacific Hospital Injectable Drugs Market Share by Type (2020-2025)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Hospital Injectable Drugs Market Size by Application (2020-2025)
6.3.3.2 Asia-Pacific Hospital Injectable Drugs Market Share by Application (2020-2025)
6.3.4 Asia-Pacific Market Trend and Opportunities
6.4 India Market: Players, Segments and Downstream
6.4.1 India Hospital Injectable Drugs Revenue by Company (2020-2025)
6.4.2 India Market Size by Type
6.4.2.1 India Hospital Injectable Drugs Market Size by Type (2020-2025)
6.4.2.2 India Hospital Injectable Drugs Market Share by Type (2020-2025)
6.4.3 India Market Size by Application
6.4.3.1 India Hospital Injectable Drugs Market Size by Application (2020-2025)
6.4.3.2 India Hospital Injectable Drugs Market Share by Application (2020-2025)
6.4.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Hospira (Pfizer Inc.)
7.1.1 Hospira (Pfizer Inc.) Company Details
7.1.2 Hospira (Pfizer Inc.) Business Overview
7.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Introduction
7.1.4 Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2020-2025)
7.1.5 Hospira (Pfizer Inc.) Recent Development
7.2 Baxter
7.2.1 Baxter Company Details
7.2.2 Baxter Business Overview
7.2.3 Baxter Hospital Injectable Drugs Introduction
7.2.4 Baxter Revenue in Hospital Injectable Drugs Business (2020-2025)
7.2.5 Baxter Recent Development
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Company Details
7.3.2 Fresenius Kabi Business Overview
7.3.3 Fresenius Kabi Hospital Injectable Drugs Introduction
7.3.4 Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2020-2025)
7.3.5 Fresenius Kabi Recent Development
7.4 Sandoz (Novartis)
7.4.1 Sandoz (Novartis) Company Details
7.4.2 Sandoz (Novartis) Business Overview
7.4.3 Sandoz (Novartis) Hospital Injectable Drugs Introduction
7.4.4 Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2020-2025)
7.4.5 Sandoz (Novartis) Recent Development
7.5 Hikma Pharmaceuticals PLC
7.5.1 Hikma Pharmaceuticals PLC Company Details
7.5.2 Hikma Pharmaceuticals PLC Business Overview
7.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Introduction
7.5.4 Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2020-2025)
7.5.5 Hikma Pharmaceuticals PLC Recent Development
7.6 Dr. Reddy’s Laboratories Ltd
7.6.1 Dr. Reddy’s Laboratories Ltd Company Details
7.6.2 Dr. Reddy’s Laboratories Ltd Business Overview
7.6.3 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Introduction
7.6.4 Dr. Reddy’s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2020-2025)
7.6.5 Dr. Reddy’s Laboratories Ltd Recent Development
7.7 Grifols
7.7.1 Grifols Company Details
7.7.2 Grifols Business Overview
7.7.3 Grifols Hospital Injectable Drugs Introduction
7.7.4 Grifols Revenue in Hospital Injectable Drugs Business (2020-2025)
7.7.5 Grifols Recent Development
7.8 Nichi-Iko Group (Sagent)
7.8.1 Nichi-Iko Group (Sagent) Company Details
7.8.2 Nichi-Iko Group (Sagent) Business Overview
7.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Introduction
7.8.4 Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2020-2025)
7.8.5 Nichi-Iko Group (Sagent) Recent Development
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Company Details
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Hospital Injectable Drugs Introduction
7.9.4 Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2020-2025)
7.9.5 Teva Pharmaceutical Recent Development
7.10 Otsuka
7.10.1 Otsuka Company Details
7.10.2 Otsuka Business Overview
7.10.3 Otsuka Hospital Injectable Drugs Introduction
7.10.4 Otsuka Revenue in Hospital Injectable Drugs Business (2020-2025)
7.10.5 Otsuka Recent Development
7.11 B.Braun
7.11.1 B.Braun Company Details
7.11.2 B.Braun Business Overview
7.11.3 B.Braun Hospital Injectable Drugs Introduction
7.11.4 B.Braun Revenue in Hospital Injectable Drugs Business (2020-2025)
7.11.5 B.Braun Recent Development
7.12 JW Life Science
7.12.1 JW Life Science Company Details
7.12.2 JW Life Science Business Overview
7.12.3 JW Life Science Hospital Injectable Drugs Introduction
7.12.4 JW Life Science Revenue in Hospital Injectable Drugs Business (2020-2025)
7.12.5 JW Life Science Recent Development
7.13 Auromedics
7.13.1 Auromedics Company Details
7.13.2 Auromedics Business Overview
7.13.3 Auromedics Hospital Injectable Drugs Introduction
7.13.4 Auromedics Revenue in Hospital Injectable Drugs Business (2020-2025)
7.13.5 Auromedics Recent Development
7.14 Sanofi
7.14.1 Sanofi Company Details
7.14.2 Sanofi Business Overview
7.14.3 Sanofi Hospital Injectable Drugs Introduction
7.14.4 Sanofi Revenue in Hospital Injectable Drugs Business (2020-2025)
7.14.5 Sanofi Recent Development
7.15 Gland Pharma
7.15.1 Gland Pharma Company Details
7.15.2 Gland Pharma Business Overview
7.15.3 Gland Pharma Hospital Injectable Drugs Introduction
7.15.4 Gland Pharma Revenue in Hospital Injectable Drugs Business (2020-2025)
7.15.5 Gland Pharma Recent Development
7.16 Endo International PLC
7.16.1 Endo International PLC Company Details
7.16.2 Endo International PLC Business Overview
7.16.3 Endo International PLC Hospital Injectable Drugs Introduction
7.16.4 Endo International PLC Revenue in Hospital Injectable Drugs Business (2020-2025)
7.16.5 Endo International PLC Recent Development
7.17 Sichuan Kelun Pharmaceutical
7.17.1 Sichuan Kelun Pharmaceutical Company Details
7.17.2 Sichuan Kelun Pharmaceutical Business Overview
7.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Introduction
7.17.4 Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2020-2025)
7.17.5 Sichuan Kelun Pharmaceutical Recent Development
7.18 Cisen Pharmaceutical
7.18.1 Cisen Pharmaceutical Company Details
7.18.2 Cisen Pharmaceutical Business Overview
7.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Introduction
7.18.4 Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2020-2025)
7.18.5 Cisen Pharmaceutical Recent Development
7.19 Shijiazhuang No. 4 Pharmaceutical
7.19.1 Shijiazhuang No. 4 Pharmaceutical Company Details
7.19.2 Shijiazhuang No. 4 Pharmaceutical Business Overview
7.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Introduction
7.19.4 Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2020-2025)
7.19.5 Shijiazhuang No. 4 Pharmaceutical Recent Development
7.20 Shandong Hualu Pharmaceutical
7.20.1 Shandong Hualu Pharmaceutical Company Details
7.20.2 Shandong Hualu Pharmaceutical Business Overview
7.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Introduction
7.20.4 Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2020-2025)
7.20.5 Shandong Hualu Pharmaceutical Recent Development
7.21 CR Double-Crane
7.21.1 CR Double-Crane Company Details
7.21.2 CR Double-Crane Business Overview
7.21.3 CR Double-Crane Hospital Injectable Drugs Introduction
7.21.4 CR Double-Crane Revenue in Hospital Injectable Drugs Business (2020-2025)
7.21.5 CR Double-Crane Recent Development
8 Hospital Injectable Drugs Market Dynamics
8.1 Hospital Injectable Drugs Industry Trends
8.2 Hospital Injectable Drugs Market Drivers
8.3 Hospital Injectable Drugs Market Challenges
8.4 Hospital Injectable Drugs Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Global Hospital Injectable Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Hospital Injectable Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Hospital Injectable Drugs Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Hospital Injectable Drugs Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Hospital Injectable Drugs Revenue Share by Region (2020-2025)
Table 6. Global Hospital Injectable Drugs Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Hospital Injectable Drugs Revenue Share Forecast by Region (2026-2031)
Table 8. Global Hospital Injectable Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Hospital Injectable Drugs Revenue Market Share by Type (2020-2025)
Table 10. Global Hospital Injectable Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Hospital Injectable Drugs Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Hospital Injectable Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Hospital Injectable Drugs Revenue Market Share by Application (2020-2025)
Table 15. Global Hospital Injectable Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Hospital Injectable Drugs Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Hospital Injectable Drugs Application
Table 18. Global Hospital Injectable Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Hospital Injectable Drugs Market Share by Players (2020-2025)
Table 20. Global Top Hospital Injectable Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Injectable Drugs as of 2024)
Table 21. Ranking of Global Top Hospital Injectable Drugs Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Hospital Injectable Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Hospital Injectable Drugs, Headquarters and Area Served
Table 24. Global Key Players of Hospital Injectable Drugs, Product and Application
Table 25. Global Key Players of Hospital Injectable Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Hospital Injectable Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Hospital Injectable Drugs Revenue Market Share by Company (2020-2025)
Table 29. North America Hospital Injectable Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Hospital Injectable Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Hospital Injectable Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Hospital Injectable Drugs Revenue Market Share by Company (2020-2025)
Table 33. Europe Hospital Injectable Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Hospital Injectable Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 35. Asia-Pacific Hospital Injectable Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 36. Asia-Pacific Hospital Injectable Drugs Revenue Market Share by Company (2020-2025)
Table 37. Asia-Pacific Hospital Injectable Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 38. Asia-Pacific Hospital Injectable Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 39. India Hospital Injectable Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 40. India Hospital Injectable Drugs Revenue Market Share by Company (2020-2025)
Table 41. India Hospital Injectable Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 42. India Hospital Injectable Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 43. Hospira (Pfizer Inc.) Company Details
Table 44. Hospira (Pfizer Inc.) Business Overview
Table 45. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product
Table 46. Hospira (Pfizer Inc.) Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 47. Hospira (Pfizer Inc.) Recent Development
Table 48. Baxter Company Details
Table 49. Baxter Business Overview
Table 50. Baxter Hospital Injectable Drugs Product
Table 51. Baxter Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 52. Baxter Recent Development
Table 53. Fresenius Kabi Company Details
Table 54. Fresenius Kabi Business Overview
Table 55. Fresenius Kabi Hospital Injectable Drugs Product
Table 56. Fresenius Kabi Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 57. Fresenius Kabi Recent Development
Table 58. Sandoz (Novartis) Company Details
Table 59. Sandoz (Novartis) Business Overview
Table 60. Sandoz (Novartis) Hospital Injectable Drugs Product
Table 61. Sandoz (Novartis) Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 62. Sandoz (Novartis) Recent Development
Table 63. Hikma Pharmaceuticals PLC Company Details
Table 64. Hikma Pharmaceuticals PLC Business Overview
Table 65. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product
Table 66. Hikma Pharmaceuticals PLC Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 67. Hikma Pharmaceuticals PLC Recent Development
Table 68. Dr. Reddy’s Laboratories Ltd Company Details
Table 69. Dr. Reddy’s Laboratories Ltd Business Overview
Table 70. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product
Table 71. Dr. Reddy’s Laboratories Ltd Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 72. Dr. Reddy’s Laboratories Ltd Recent Development
Table 73. Grifols Company Details
Table 74. Grifols Business Overview
Table 75. Grifols Hospital Injectable Drugs Product
Table 76. Grifols Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 77. Grifols Recent Development
Table 78. Nichi-Iko Group (Sagent) Company Details
Table 79. Nichi-Iko Group (Sagent) Business Overview
Table 80. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product
Table 81. Nichi-Iko Group (Sagent) Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 82. Nichi-Iko Group (Sagent) Recent Development
Table 83. Teva Pharmaceutical Company Details
Table 84. Teva Pharmaceutical Business Overview
Table 85. Teva Pharmaceutical Hospital Injectable Drugs Product
Table 86. Teva Pharmaceutical Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 87. Teva Pharmaceutical Recent Development
Table 88. Otsuka Company Details
Table 89. Otsuka Business Overview
Table 90. Otsuka Hospital Injectable Drugs Product
Table 91. Otsuka Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 92. Otsuka Recent Development
Table 93. B.Braun Company Details
Table 94. B.Braun Business Overview
Table 95. B.Braun Hospital Injectable Drugs Product
Table 96. B.Braun Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 97. B.Braun Recent Development
Table 98. JW Life Science Company Details
Table 99. JW Life Science Business Overview
Table 100. JW Life Science Hospital Injectable Drugs Product
Table 101. JW Life Science Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 102. JW Life Science Recent Development
Table 103. Auromedics Company Details
Table 104. Auromedics Business Overview
Table 105. Auromedics Hospital Injectable Drugs Product
Table 106. Auromedics Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 107. Auromedics Recent Development
Table 108. Sanofi Company Details
Table 109. Sanofi Business Overview
Table 110. Sanofi Hospital Injectable Drugs Product
Table 111. Sanofi Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 112. Sanofi Recent Development
Table 113. Gland Pharma Company Details
Table 114. Gland Pharma Business Overview
Table 115. Gland Pharma Hospital Injectable Drugs Product
Table 116. Gland Pharma Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 117. Gland Pharma Recent Development
Table 118. Endo International PLC Company Details
Table 119. Endo International PLC Business Overview
Table 120. Endo International PLC Hospital Injectable Drugs Product
Table 121. Endo International PLC Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 122. Endo International PLC Recent Development
Table 123. Sichuan Kelun Pharmaceutical Company Details
Table 124. Sichuan Kelun Pharmaceutical Business Overview
Table 125. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product
Table 126. Sichuan Kelun Pharmaceutical Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 127. Sichuan Kelun Pharmaceutical Recent Development
Table 128. Cisen Pharmaceutical Company Details
Table 129. Cisen Pharmaceutical Business Overview
Table 130. Cisen Pharmaceutical Hospital Injectable Drugs Product
Table 131. Cisen Pharmaceutical Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 132. Cisen Pharmaceutical Recent Development
Table 133. Shijiazhuang No. 4 Pharmaceutical Company Details
Table 134. Shijiazhuang No. 4 Pharmaceutical Business Overview
Table 135. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product
Table 136. Shijiazhuang No. 4 Pharmaceutical Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 137. Shijiazhuang No. 4 Pharmaceutical Recent Development
Table 138. Shandong Hualu Pharmaceutical Company Details
Table 139. Shandong Hualu Pharmaceutical Business Overview
Table 140. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product
Table 141. Shandong Hualu Pharmaceutical Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 142. Shandong Hualu Pharmaceutical Recent Development
Table 143. CR Double-Crane Company Details
Table 144. CR Double-Crane Business Overview
Table 145. CR Double-Crane Hospital Injectable Drugs Product
Table 146. CR Double-Crane Revenue in Hospital Injectable Drugs Business (2020-2025) & (US$ Million)
Table 147. CR Double-Crane Recent Development
Table 148. Hospital Injectable Drugs Market Trends
Table 149. Hospital Injectable Drugs Market Drivers
Table 150. Hospital Injectable Drugs Market Challenges
Table 151. Hospital Injectable Drugs Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources


List of Figures
Figure 1. Hospital Injectable Drugs Product Picture
Figure 2. Global Hospital Injectable Drugs Market Share by Type: 2024 VS 2031
Figure 3. Generic Sterile Injectables Features
Figure 4. Sterile Intravenous (IV) Solutions Features
Figure 5. Global Hospital Injectable Drugs Market Share by Application: 2024 VS 2031
Figure 6. Oncology
Figure 7. Anesthesia
Figure 8. Anti-Infectives
Figure 9. Parenteral Nutrition
Figure 10. Cardiovascular Diseases
Figure 11. Hospital Injectable Drugs Report Years Considered
Figure 12. Global Hospital Injectable Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Hospital Injectable Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Hospital Injectable Drugs Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Hospital Injectable Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Hospital Injectable Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Asia-Pacific Hospital Injectable Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. India Hospital Injectable Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Hospital Injectable Drugs Market Share by Players in 2024
Figure 20. Global Top Hospital Injectable Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Injectable Drugs as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Hospital Injectable Drugs Revenue in 2024
Figure 22. North America Hospital Injectable Drugs Market Share by Type (2020-2025)
Figure 23. North America Hospital Injectable Drugs Market Share by Application (2020-2025)
Figure 24. Europe Hospital Injectable Drugs Market Share by Type (2020-2025)
Figure 25. Europe Hospital Injectable Drugs Market Share by Application (2020-2025)
Figure 26. Asia-Pacific Hospital Injectable Drugs Market Share by Type (2020-2025)
Figure 27. Asia-Pacific Hospital Injectable Drugs Market Share by Application (2020-2025)
Figure 28. India Hospital Injectable Drugs Market Share by Type (2020-2025)
Figure 29. India Hospital Injectable Drugs Market Share by Application (2020-2025)
Figure 30. Hospira (Pfizer Inc.) Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 31. Baxter Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 32. Fresenius Kabi Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 33. Sandoz (Novartis) Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 34. Hikma Pharmaceuticals PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 35. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 36. Grifols Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 37. Nichi-Iko Group (Sagent) Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 38. Teva Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 39. Otsuka Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 40. B.Braun Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 41. JW Life Science Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 42. Auromedics Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 43. Sanofi Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 44. Gland Pharma Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 45. Endo International PLC Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 46. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 47. Cisen Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 48. Shijiazhuang No. 4 Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 49. Shandong Hualu Pharmaceutical Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 50. CR Double-Crane Revenue Growth Rate in Hospital Injectable Drugs Business (2020-2025)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit